BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 11681590)

  • 21. Enhanced apomorphine sensitivity and increased binding of dopamine D2 receptors in nucleus accumbens in prepubertal rats after neonatal blockade of the dopamine D3 receptors by (+)-S14297.
    Flores-Tochihuitl J; Vargas G; Morales-Medina JC; Rivera G; De La Cruz F; Zamudio S; Flores G
    Synapse; 2008 Jan; 62(1):40-9. PubMed ID: 17957737
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Dopamine D3 receptor antisense oligodeoxynucleotide potentiates imipramine-induced dopaminergic behavioural supersensitivity.
    D'Aquila PS; Panin F; Castelli MP; Serra G
    Behav Pharmacol; 2006 Mar; 17(2):101-6. PubMed ID: 16495718
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of dopamine in behavioral sensitization to ethanol in DBA/2J mice.
    Broadbent J; Kampmueller KM; Koonse SA
    Alcohol; 2005 Feb; 35(2):137-48. PubMed ID: 15963427
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subchronic caffeine administration sensitizes rats to the motor-activating effects of dopamine D(1) and D(2) receptor agonists.
    Cauli O; Morelli M
    Psychopharmacology (Berl); 2002 Jul; 162(3):246-54. PubMed ID: 12122482
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Repeated administration of a dopamine D1 receptor agonist reverses the increased proportions of striatal dopamine D1High and D2High receptors in methamphetamine-sensitized rats.
    Shuto T; Seeman P; Kuroiwa M; Nishi A
    Eur J Neurosci; 2008 May; 27(10):2551-7. PubMed ID: 18489579
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Dopamine D3 receptor stimulation underlies the development of L-DOPA-induced dyskinesia in animal models of Parkinson's disease.
    Visanji NP; Fox SH; Johnston T; Reyes G; Millan MJ; Brotchie JM
    Neurobiol Dis; 2009 Aug; 35(2):184-92. PubMed ID: 19118628
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Receptor subtype-specific dopaminergic agents and unconditioned behavior.
    Beninger RJ; Mazurski EJ; Hoffman DC
    Pol J Pharmacol Pharm; 1991; 43(6):507-28. PubMed ID: 1687945
    [TBL] [Abstract][Full Text] [Related]  

  • 28. D2 dopamine receptor antisense oligodeoxynucleotide inhibits the synthesis of a functional pool of D2 dopamine receptors.
    Qin ZH; Zhou LW; Zhang SP; Wang Y; Weiss B
    Mol Pharmacol; 1995 Oct; 48(4):730-7. PubMed ID: 7476901
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Amphetamine-induced locomotion, behavioral sensitization to amphetamine, and striatal D2 receptor function in rats with high or low spontaneous exploratory activity: differences in the role of locus coeruleus.
    Alttoa A; Eller M; Herm L; Rinken A; Harro J
    Brain Res; 2007 Feb; 1131(1):138-48. PubMed ID: 17156751
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Toward a molecular understanding of psychostimulant actions using genetically engineered dopamine receptor knockout mice as model systems.
    Zhang J; Xu M
    J Addict Dis; 2001; 20(3):7-18. PubMed ID: 11681595
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of dopamine D3 receptor expression as a mechanism of behavioral sensitization to levodopa.
    Bordet R; Ridray S; Carboni S; Diaz J; Sokoloff P; Schwartz JC
    Proc Natl Acad Sci U S A; 1997 Apr; 94(7):3363-7. PubMed ID: 9096399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The D3 dopamine receptor in cellular and organismal function.
    Shafer RA; Levant B
    Psychopharmacology (Berl); 1998 Jan; 135(1):1-16. PubMed ID: 9489928
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Exposure to bisphenol-A affects the rewarding system in mice].
    Suzuki T; Mizuo K; Miyagawa K; Narita M
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2005 Jun; 25(3):125-8. PubMed ID: 16045194
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of the dopamine antagonist PD 152255 on juvenile rats' responses to dorsal stimulation, the transport response, and related behaviors.
    Wilson C; Pulido M
    Behav Neurosci; 2002 Dec; 116(6):1098-102. PubMed ID: 12492309
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dopamine D3 receptor ligands for drug addiction treatment: update on recent findings.
    Le Foll B; Collo G; Rabiner EA; Boileau I; Merlo Pich E; Sokoloff P
    Prog Brain Res; 2014; 211():255-75. PubMed ID: 24968784
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neural substrates of drug craving and relapse in drug addiction.
    Self DW
    Ann Med; 1998 Aug; 30(4):379-89. PubMed ID: 9783837
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypothetical dopamine dynamics in mania and psychosis--its pharmacokinetic implications.
    Park SY; Kang UG
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Jun; 43():89-95. PubMed ID: 23268190
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Role of dopamine D3 receptors in the addictive properties of ethanol.
    Heidbreder CA; Andreoli M; Marcon C; Thanos PK; Ashby CR; Gardner EL
    Drugs Today (Barc); 2004 Apr; 40(4):355-65. PubMed ID: 15190388
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A targeted mutation of the D3 dopamine receptor gene is associated with hyperactivity in mice.
    Accili D; Fishburn CS; Drago J; Steiner H; Lachowicz JE; Park BH; Gauda EB; Lee EJ; Cool MH; Sibley DR; Gerfen CR; Westphal H; Fuchs S
    Proc Natl Acad Sci U S A; 1996 Mar; 93(5):1945-9. PubMed ID: 8700864
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Intensification of the development of ethanol dependence in mice lacking dopamine D(3) receptor.
    Narita M; Soma M; Tamaki H; Narita M; Suzuki T
    Neurosci Lett; 2002 May; 324(2):129-32. PubMed ID: 11988344
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.